These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35853010)

  • 1. SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver disease.
    Gomez-Torres O; Amatya S; Kamberov L; Dhaibar HA; Khanna P; Rom O; Yurdagul A; Orr AW; Nunez K; Thevenot P; Cohen A; Samant H; Alexander JS; Burgos-Ramos E; Chapa-Rodriguez A; Cruz-Topete D
    Am J Physiol Gastrointest Liver Physiol; 2022 Sep; 323(3):G177-G187. PubMed ID: 35853010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.
    Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y
    J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
    Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
    Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting alkaline ceramidase 3 alleviates the severity of nonalcoholic steatohepatitis by reducing oxidative stress.
    Wang K; Li C; Lin X; Sun H; Xu R; Li Q; Wei Y; Li Y; Qian J; Liu C; Zhang Q; Yu S; Cui Z; Huang X; Zhu B; Zhou J; Mao C
    Cell Death Dis; 2020 Jan; 11(1):28. PubMed ID: 31949129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte-specific loss of LAP2α protects against diet-induced hepatic steatosis, steatohepatitis, and fibrosis in male mice.
    Upadhyay KK; Choi EK; Foisner R; Omary MB; Brady GF
    Am J Physiol Gastrointest Liver Physiol; 2023 Aug; 325(2):G184-G195. PubMed ID: 37366543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis.
    Lee C; Kim J; Han J; Oh D; Kim M; Jeong H; Kim TJ; Kim SW; Kim JN; Seo YS; Suzuki A; Kim JH; Jung Y
    Nat Commun; 2022 Jan; 13(1):578. PubMed ID: 35102146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages.
    Tao L; Yi Y; Chen Y; Zhang H; Orning P; Lien E; Jie J; Zhang W; Xu Q; Li Y; Ding Z; Wu C; Ding Q; Wang J; Zhang J; Weng D
    Cell Death Differ; 2021 Apr; 28(4):1418-1433. PubMed ID: 33208891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Lee C; Kim J; Jung Y
    Cells; 2019 Oct; 8(10):. PubMed ID: 31619023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL5 promotes lipotoxicity of hepatocytes through upregulating NLRP3/Caspase-1/IL-1β signaling in Kupffer cells and exacerbates nonalcoholic steatohepatitis in mice.
    Qi J; Yan X; Li L; Qiu K; Huang W; Zhou Z
    Int Immunopharmacol; 2023 Oct; 123():110752. PubMed ID: 37573690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective and Detrimental Roles of p38α Mitogen-Activated Protein Kinase in Different Stages of Nonalcoholic Fatty Liver Disease.
    Hwang S; Wang X; Rodrigues RM; Ma J; He Y; Seo W; Park SH; Kim SJ; Feng D; Gao B
    Hepatology; 2020 Sep; 72(3):873-891. PubMed ID: 32463484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.
    Li S; Li X; Chen F; Liu M; Ning L; Yan Y; Zhang S; Huang S; Tu C
    J Nutr Biochem; 2022 Feb; 100():108888. PubMed ID: 34695558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLD.
    Marsal-Beltran A; Rodríguez-Castellano A; Astiarraga B; Calvo E; Rada P; Madeira A; Rodríguez-Peña MM; Llauradó G; Núñez-Roa C; Gómez-Santos B; Maymó-Masip E; Bosch R; Frutos MD; Moreno-Navarrete JM; Ramos-Molina B; Aspichueta P; Joven J; Fernández-Real JM; Quer JC; Valverde ÁM; Pardo A; Vendrell J; Ceperuelo-Mallafré V; Fernández-Veledo S
    Metabolism; 2023 Aug; 145():155630. PubMed ID: 37315889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis.
    Machado MV; Michelotti GA; Pereira Tde A; Boursier J; Kruger L; Swiderska-Syn M; Karaca G; Xie G; Guy CD; Bohinc B; Lindblom KR; Johnson E; Kornbluth S; Diehl AM
    Gut; 2015 Jul; 64(7):1148-57. PubMed ID: 25053716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of sphingosine 1-phosphate signaling ameliorates murine nonalcoholic steatohepatitis.
    Mauer AS; Hirsova P; Maiers JL; Shah VH; Malhi H
    Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G300-G313. PubMed ID: 28039158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Extracellular RNA Mitigates Hepatic Lipotoxicity and Liver Injury in NASH.
    Tewari A; Rajak S; Raza S; Gupta P; Chakravarti B; Srivastava J; Chaturvedi CP; Sinha RA
    Cells; 2023 Jul; 12(14):1845. PubMed ID: 37484201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and non-alcoholic fatty liver diseases.
    Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
    World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A TNFα/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates non-alcoholic steatohepatitis.
    Jin K; Shi Y; Zhang H; Zhangyuan G; Wang F; Li S; Chen C; Zhang J; Wang H; Zhang W; Sun B
    J Hepatol; 2023 Aug; 79(2):403-416. PubMed ID: 37040844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis.
    Mukherjee S; Chakraborty M; Ulmasov B; McCommis K; Zhang J; Carpenter D; Msengi EN; Haubner J; Guo C; Pike DP; Ghoshal S; Ford DA; Neuschwander-Tetri BA; Chakraborty A
    Mol Metab; 2021 Dec; 54():101364. PubMed ID: 34757046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.